아스피린 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "아스피린" in Korean language version.

refsWebsite

Global rank Korean rank

51nih.gov

4^th place

46doi.org

2^nd place

3^rd place

18web.archive.org

1^st place

12semanticscholar.org

11^th place

310^th place

12archive.org

6^th place

18^th place

4books.google.com

3^rd place

9^th place

3drugs.com

399^th place

141^st place

3handle.net

102^nd place

307^th place

2medicinescomplete.com

low place

3,855^th place

2mfds.go.kr

low place

1,240^th place

2fda.gov

447^th place

433^rd place

2harvard.edu

18^th place

27^th place

2cdc.gov

218^th place

52^nd place

2medscape.com

719^th place

424^th place

1hankookilbo.com

3,275^th place

57^th place

1chosun.com

342^nd place

8^th place

1health.kr

low place

2,285^th place

1lsnbestclinic.com

low place

1bktimes.net

low place

7,043^rd place

1uspreventiveservicestaskforce.org

low place

1healthychildren.org

low place

1healtip.co.kr

low place

1snu.ac.kr

low place

179^th place

1mayoclinic.org

1,610^th place

869^th place

1clevelandclinic.org

4,925^th place

4,695^th place

1personalmd.com

low place

1jpp.krakow.pl

low place

1mercksource.com

8,363^rd place

1,523^rd place

1merckvetmanual.com

9,011^th place

2,902^nd place

1merckmanuals.com

3,097^th place

1,083^rd place

1cornell.edu

332^nd place

338^th place

archive.org

Kingery WS (November 1997). “A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes”. 《Pain》 73 (2): 123–139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498. S2CID 10418793.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, 외. (September 2000). “Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin”. 《The American Journal of Gastroenterology》 95 (9): 2218–24. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Laine L, Maller ES, Yu C, Quan H, Simon T (August 2004). “Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial”. 《Gastroenterology》 127 (2): 395–402. doi:10.1053/j.gastro.2004.05.001. PMID 15300570.
Marx J (2006). 《Rosen's emergency medicine: concepts and clinical practice》. Mosby/Elsevier. 2242쪽. ISBN 978-0-323-02845-5.
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). “Serum concentrations of salicylic acid following topically applied salicylate derivatives”. 《The Annals of Pharmacotherapy》 30 (9): 935–40. doi:10.1177/106002809603000903. PMID 8876850. S2CID 9843820.
Baselt R (2011). 《Disposition of toxic drugs and chemicals in man》 9판. Seal Beach, California: Biomedical Publications. 20–23쪽. ISBN 978-0-9626523-8-7.
Hollifield JW (August 1976). “Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.”. 《Southern Medical Journal》 69 (8): 1034–6. doi:10.1097/00007611-197608000-00022. PMID 785608.
Katzung BG (1998). 《Basic and clinical pharmacology》. McGraw-Hill. 584쪽. ISBN 978-0-8385-0565-6.
Reynolds EF, 편집. (1982). 〈Aspirin and similar analgesic and anti-inflammatory agents〉. 《Martindale: the extra pharmacopoeia》 28판. Rittenhouse Book Distributors. 234–82쪽. ISBN 978-0-85369-160-0.
Kaufman FL, Dubansky AS (April 1972). “Darvon poisoning with delayed salicylism: a case report”. 《Pediatrics》 49 (4): 610–1. doi:10.1542/peds.49.4.610. PMID 5013423. S2CID 29427204.
Done AK (November 1960). “Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion”. 《Pediatrics》 26: 800–7. doi:10.1542/peds.26.5.800. PMID 13723722. S2CID 245036862.
Lappin MR, 편집. (2001). 《Feline internal medicine secrets》. Philadelphia: Hanley & Belfus. 160쪽. ISBN 978-1-56053-461-7.

bktimes.net

'아스피린프로텍트'vs'아스트릭스', 과연 1위는, 보건타임즈, 2009년 1월 11일

books.google.com

Jones A (2015). 《Chemistry: An Introduction for Medical and Health Sciences》. John Wiley & Sons. 5–6쪽. ISBN 978-0-470-09290-3.
Ravina E (2011). 《The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs》. John Wiley & Sons. 24쪽. ISBN 978-3-527-32669-3.
Jeffreys D (2008). 《Aspirin the remarkable story of a wonder drug.》. Bloomsbury Publishing USA. ISBN 978-1-59691-816-0. 2017년 9월 8일에 원본 문서에서 보존된 문서. ^:46–48
Livingstone FB (1985). 《Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations》. Oxford University Press. ISBN 978-0-19-503634-3.

cdc.gov

“Dengue and dengue hemorrhagic fever: information for health care practitioners”. 2008년 3월 17일에 원본 문서에서 보존된 문서. 2008년 4월 28일에 확인함.
“Acetylsalicylic acid”. 《NIOSH Pocket Guide to Chemical Hazards》. U.S. National Institute for Occupational Safety and Health (NIOSH). 2016년 4월 11일. 2017년 5월 11일에 원본 문서에서 보존된 문서.

chosun.com

m.health.chosun.com

용량 따라 달라지는 아스피린의 효과, 조선일보, 2020년 6월 6일

clevelandclinic.org

health.clevelandclinic.org

“Are You Sensitive to Aspirin? Here are Some Reasons Why”. 《Health Essentials from Cleveland Clinic》. 2015년 2월 5일. 2020년 10월 25일에 원본 문서에서 보존된 문서. 2020년 3월 5일에 확인함.

cornell.edu

ansci.cornell.edu

“Plants poisonous to livestock”. Cornell University Department of Animal Science. 2015년 8월 16일에 원본 문서에서 보존된 문서. 2016년 3월 3일에 확인함.

doi.org

dx.doi.org

Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, 외. (February 2012). “Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials”. 《Archives of Internal Medicine》 172 (3): 209–16. doi:10.1001/archinternmed.2011.628. hdl:10044/1/34287. PMID 22231610.
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, 외. (October 2018). “Effect of Aspirin on Disability-free Survival in the Healthy Elderly”. 《The New England Journal of Medicine》 379 (16): 1499–1508. doi:10.1056/NEJMoa1800722. hdl:1885/154654. PMC 6426126. PMID 30221596.
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, 외. (October 2018). “Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly”. 《The New England Journal of Medicine》 379 (16): 1509–1518. doi:10.1056/NEJMoa1805819. PMC 6289056. PMID 30221597.
Algra AM, Rothwell PM (May 2012). “Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials”. 《The Lancet. Oncology》 13 (5): 518–27. doi:10.1016/S1470-2045(12)70112-2. PMID 22440112.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, 외. (April 2022). “Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement”. 《JAMA》 327 (16): 1577–1584. doi:10.1001/jama.2022.4983. PMID 35471505. S2CID 248390304.
Gaciong Z (June 2003). “The real dimension of analgesic activity of aspirin”. 《Thrombosis Research》 110 (5–6): 361–4. doi:10.1016/j.thromres.2003.08.009. PMID 14592563.
Derry CJ, Derry S, Moore RA (December 2014). “Caffeine as an analgesic adjuvant for acute pain in adults”. 《The Cochrane Database of Systematic Reviews》 2014 (12): CD009281. doi:10.1002/14651858.CD009281.pub3. PMC 6485702. PMID 25502052.
Hersh EV, Moore PA, Ross GL (May 2000). “Over-the-counter analgesics and antipyretics: a critical assessment”. 《Clinical Therapeutics》 22 (5): 500–48. doi:10.1016/S0149-2918(00)80043-0. PMID 10868553.
Mett A, Tfelt-Hansen P (June 2008). “Acute migraine therapy: recent evidence from randomized comparative trials”. 《Current Opinion in Neurology》 21 (3): 331–7. doi:10.1097/WCO.0b013e3282fee843. PMID 18451718. S2CID 44459366.
Kingery WS (November 1997). “A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes”. 《Pain》 73 (2): 123–139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498. S2CID 10418793.
Loder E, Rizzoli P (January 2008). “Tension-type headache”. 《BMJ》 336 (7635): 88–92. doi:10.1136/bmj.39412.705868.AD. PMC 2190284. PMID 18187725.
Bartfai T, Conti B (March 2010). “Fever”. 《TheScientificWorldJournal》 10: 490–503. doi:10.1100/tsw.2010.50. PMC 2850202. PMID 20305990.
Pugliese A, Beltramo T, Torre D (October 2008). “Reye's and Reye's-like syndromes”. 《Cell Biochemistry and Function》 26 (7): 741–6. doi:10.1002/cbf.1465. PMID 18711704. S2CID 22361194.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, 외. (September 2000). “Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin”. 《The American Journal of Gastroenterology》 95 (9): 2218–24. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Delaney JA, Opatrny L, Brophy JM, Suissa S (August 2007). “Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding”. 《CMAJ》 177 (4): 347–51. doi:10.1503/cmaj.070186. PMC 1942107. PMID 17698822.
Laine L, Maller ES, Yu C, Quan H, Simon T (August 2004). “Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial”. 《Gastroenterology》 127 (2): 395–402. doi:10.1053/j.gastro.2004.05.001. PMID 15300570.
Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, 외. (September 2003). “Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa”. 《Proceedings of the National Academy of Sciences of the United States of America》 100 (19): 10937–41. Bibcode:2003PNAS..10010937F. doi:10.1073/pnas.1933204100. PMC 196906. PMID 12960371.
Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, 외. (July 2007). “Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review”. 《Clinical Gastroenterology and Hepatology》 5 (7): 818–28, 828.e1–5; quiz 768. doi:10.1016/j.cgh.2007.03.011. PMID 17556027.
Doña I, Barrionuevo E, Salas M, Laguna JJ, Agúndez J, García-Martín E, 외. (November 2018). “NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs”. 《Scientific Reports》 8 (1): 16710. Bibcode:2018NatSR...816710D. doi:10.1038/s41598-018-34668-1. PMC 6232098. PMID 30420763.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, 외. (January 2019). “Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper”. 《Allergy》 74 (1): 28–39. doi:10.1111/all.13599. PMID 30216468. S2CID 52276808.
Sánchez-Borges M, Capriles-Hulett A (January 2000). “Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity”. 《Annals of Allergy, Asthma & Immunology》 84 (1): 101–6. doi:10.1016/S1081-1206(10)62748-2. PMID 10674573.
Stadelmann WK, Digenis AG, Tobin GR (August 1998). “Impediments to wound healing”. 《American Journal of Surgery》 176 (2A Suppl): 39S–47S. doi:10.1016/S0002-9610(98)00184-6. PMID 9777971.
Layton AM, Ibbotson SH, Davies JA, Goodfield MJ (July 1994). “Randomised trial of oral aspirin for chronic venous leg ulcers”. 《Lancet》 344 (8916): 164–5. doi:10.1016/s0140-6736(94)92759-6. PMID 7912767. S2CID 912169.
del Río Solá ML, Antonio J, Fajardo G, Vaquero Puerta C (July 2012). “Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency”. 《Annals of Vascular Surgery》 26 (5): 620–9. doi:10.1016/j.avsg.2011.02.051. hdl:10324/2904. PMID 22437068.
de Oliveira Carvalho PE, Magolbo NG, De Aquino RF, Weller CD, 외. (Cochrane Wounds Group) (February 2016). “Oral aspirin for treating venous leg ulcers”. 《The Cochrane Database of Systematic Reviews》 2016 (2): CD009432. doi:10.1002/14651858.CD009432.pub2. PMC 8627253. PMID 26889740.
Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J (November 2017). “Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)”. 《BMJ》 359: j5157. doi:10.1136/bmj.j5157. PMC 5701114. PMID 29175902.
Tilbrook H, Clark L, Cook L, Bland M, Buckley H, Chetter I, 외. (October 2018). “AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial”. 《Health Technology Assessment》 22 (55): 1–138. doi:10.3310/hta22550. PMC 6204573. PMID 30325305.
Gaudreault P, Temple AR, Lovejoy FH (October 1982). “The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison”. 《Pediatrics》 70 (4): 566–9. doi:10.1542/peds.70.4.566. PMID 7122154. S2CID 12738659. (primary source)
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). “Serum concentrations of salicylic acid following topically applied salicylate derivatives”. 《The Annals of Pharmacotherapy》 30 (9): 935–40. doi:10.1177/106002809603000903. PMID 8876850. S2CID 9843820.
Senna GE, Andri G, Dama AR, Mezzelani P, Andri L (1995). “Tolerability of imidazole salycilate in aspirin-sensitive patients”. 《Allergy Proceedings》 16 (5): 251–4. doi:10.2500/108854195778702675. PMID 8566739.
Macdonald S (November 2002). “Aspirin use to be banned in under 16 year olds”. 《BMJ》 325 (7371): 988c–988. doi:10.1136/bmj.325.7371.988/c. PMC 1169585. PMID 12411346.
Alqahtani Z, Jamali F (2018). “Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review”. 《Journal of Pharmacy & Pharmaceutical Sciences》 21 (1s): 48s–73s. doi:10.18433/jpps29854. PMID 29891025. S2CID 48361086.
Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N (April 2008). “The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers”. 《The American Journal of Cardiology》 101 (7): 1060–1063. doi:10.1016/j.amjcard.2007.11.054. PMID 18359332.
Hollifield JW (August 1976). “Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.”. 《Southern Medical Journal》 69 (8): 1034–6. doi:10.1097/00007611-197608000-00022. PMID 785608.
Loh HS, Watters K, Wilson CW (1973년 11월 1일). “The effects of aspirin on the metabolic availability of ascorbic acid in human beings”. 《Journal of Clinical Pharmacology》 13 (11): 480–486. doi:10.1002/j.1552-4604.1973.tb00203.x. PMID 4490672.
Ioannides C, Stone AN, Breacker PJ, Basu TK (December 1982). “Impairment of absorption of ascorbic acid following ingestion of aspirin in guinea pigs”. 《Biochemical Pharmacology》 31 (24): 4035–4038. doi:10.1016/0006-2952(82)90652-9. PMID 6818974.
Ferguson RK, Boutros AR (August 1970). “Death following self-poisoning with aspirin”. 《JAMA》 213 (7): 1186–8. doi:10.1001/jama.213.7.1186. PMID 5468267.
Kaufman FL, Dubansky AS (April 1972). “Darvon poisoning with delayed salicylism: a case report”. 《Pediatrics》 49 (4): 610–1. doi:10.1542/peds.49.4.610. PMID 5013423. S2CID 29427204.
Levy G, Tsuchiya T (August 1972). “Salicylate accumulation kinetics in man”. 《The New England Journal of Medicine》 287 (9): 430–2. doi:10.1056/NEJM197208312870903. PMID 5044917.
Grootveld M, Halliwell B (January 1988). “2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism”. 《Biochemical Pharmacology》 37 (2): 271–80. doi:10.1016/0006-2952(88)90729-0. PMID 3342084.
Hartwig-Otto H (November 1983). “Pharmacokinetic considerations of common analgesics and antipyretics”. 《The American Journal of Medicine》 75 (5A): 30–7. doi:10.1016/0002-9343(83)90230-9. PMID 6606362.
Done AK (November 1960). “Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion”. 《Pediatrics》 26: 800–7. doi:10.1542/peds.26.5.800. PMID 13723722. S2CID 245036862.
Chyka PA, Erdman AR, Christianson G, Wax PM, Booze LL, Manoguerra AS, 외. (2007). “Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management”. 《Clinical Toxicology》 45 (2): 95–131. doi:10.1080/15563650600907140. PMID 17364628.
Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT (November 1982). “Diuresis or urinary alkalinisation for salicylate poisoning?”. 《British Medical Journal》 285 (6352): 1383–6. doi:10.1136/bmj.285.6352.1383. PMC 1500395. PMID 6291695.
Dargan PI, Wallace CI, Jones AL (May 2002). “An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose”. 《Emergency Medicine Journal》 19 (3): 206–9. doi:10.1136/emj.19.3.206. PMC 1725844. PMID 11971828.
D'Agati V (July 1996). “Does aspirin cause acute or chronic renal failure in experimental animals and in humans?”. 《American Journal of Kidney Diseases》 28 (1 Suppl 1): S24–9. doi:10.1016/s0272-6386(96)90565-x. PMID 8669425.

drugs.com

“Aspirin Use During Pregnancy”. 《Drugs.com》. 2018년 4월 2일. 2019년 12월 29일에 확인함.
“Aspirin”. American Society of Health-System Pharmacists. 2021년 11월 29일. 2017년 4월 25일에 원본 문서에서 보존된 문서 – Drugs.com 경유.
“Aspirin information from Drugs.com”. Drugs.com. 2008년 5월 9일에 원본 문서에서 보존된 문서. 2008년 5월 8일에 확인함.

fda.gov

본 문서에는 현재 퍼블릭 도메인에 속한 다음 저작물을 기초로 작성된 내용이 포함되어 있습니다: “Aspirin for reducing your risk of heart attack and stroke: know the facts”. U.S. Food and Drug Administration (FDA). 2012년 8월 14일에 원본 문서에서 보존된 문서. 2012년 7월 26일에 확인함.
“51 FR 8180” (PDF). 《United States Federal Register》 51 (45). 1986년 3월 7일. 2011년 8월 19일에 원본 문서 (PDF)에서 보존된 문서.

handle.net

hdl.handle.net

Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, 외. (February 2012). “Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials”. 《Archives of Internal Medicine》 172 (3): 209–16. doi:10.1001/archinternmed.2011.628. hdl:10044/1/34287. PMID 22231610.
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, 외. (October 2018). “Effect of Aspirin on Disability-free Survival in the Healthy Elderly”. 《The New England Journal of Medicine》 379 (16): 1499–1508. doi:10.1056/NEJMoa1800722. hdl:1885/154654. PMC 6426126. PMID 30221596.
del Río Solá ML, Antonio J, Fajardo G, Vaquero Puerta C (July 2012). “Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency”. 《Annals of Vascular Surgery》 26 (5): 620–9. doi:10.1016/j.avsg.2011.02.051. hdl:10324/2904. PMID 22437068.

hankookilbo.com

최윤필 (2017년 3월 5일). “아스피린”. 《한국일보》. 2017년 4월 3일에 확인함.

harvard.edu

adsabs.harvard.edu

Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, 외. (September 2003). “Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa”. 《Proceedings of the National Academy of Sciences of the United States of America》 100 (19): 10937–41. Bibcode:2003PNAS..10010937F. doi:10.1073/pnas.1933204100. PMC 196906. PMID 12960371.
Doña I, Barrionuevo E, Salas M, Laguna JJ, Agúndez J, García-Martín E, 외. (November 2018). “NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs”. 《Scientific Reports》 8 (1): 16710. Bibcode:2018NatSR...816710D. doi:10.1038/s41598-018-34668-1. PMC 6232098. PMID 30420763.

health.kr

아스피린, 약물백과, 약학정보원

healthychildren.org

“Medications Used to Treat Fever”. American Academy of Pediatrics. 2013년 2월 18일에 원본 문서에서 보존된 문서. 2012년 11월 25일에 확인함.

healtip.co.kr

심혈관 질환 예방? ‘아스피린’ 복용 전 알아야할 효과 & 부작용, Healtip, 2020년 7월 25일

jpp.krakow.pl

Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, 외. (September 2005). “Significance of salicylate intolerance in diseases of the lower gastrointestinal tract” (PDF). 《Journal of Physiology and Pharmacology》 56 (Suppl 5): 89–102. PMID 16247191. 2011년 4월 9일에 원본 문서 (PDF)에서 보존된 문서.

lsnbestclinic.com

아스피린의 종류와 복용법, 이승남 강남베스트병원

mayoclinic.org

newsnetwork.mayoclinic.org

Torborg L (2018년 12월 4일). “Mayo Clinic Q and A: Coated aspirin may not be as effective at reducing blood clot risk”. 《Mayo Clinic News Network》.

medicinescomplete.com

Brayfield, A, 편집. (2014년 1월 14일). “Aspirin”. 《Martindale: The Complete Drug Reference》. Pharmaceutical Press. 2014년 4월 3일에 확인함.
Baxter K, Preston CL (편집.). “Aspirin and Spironolactone”. 《MedicinesComplete: Stockley’s Drug Interactions.》. Royal Pharmaceutical Society.

medscape.com

reference.medscape.com

“Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more”. 《Medscape Reference》. WebMD. 2014년 4월 7일에 원본 문서에서 보존된 문서. 2014년 4월 3일에 확인함.

misc.medscape.com

Kreplick LW (2001). “Salicylate toxicity in emergency medicine”. Medscape. 2012년 8월 31일에 원본 문서에서 보존된 문서.

merckmanuals.com

“Analgesics (toxicity)”. Merck. 2015년 4월 11일에 원본 문서에서 보존된 문서. 2018년 1월 19일에 확인함.

mercksource.com

“PDR guide to over the counter (OTC) drugs”. 2008년 4월 10일에 원본 문서에서 보존된 문서. 2008년 4월 28일에 확인함.

merckvetmanual.com

Edwards SH. “Nonsteroidal Anti-inflammatory Drugs: Aspirin”. 《Merck Veterinary Manual》. 2016년 12월 18일에 원본 문서에서 보존된 문서. 2018년 1월 20일에 확인함.

mfds.go.kr

nedrug.mfds.go.kr

바이엘아스피린정500밀리그람, 식품의약품안전처 의약품통합정보
아스피린프로텍트정100밀리그람, 식품의약품안전처 의약품통합정보

nih.gov

ncbi.nlm.nih.gov

Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, 외. (February 2012). “Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials”. 《Archives of Internal Medicine》 172 (3): 209–16. doi:10.1001/archinternmed.2011.628. hdl:10044/1/34287. PMID 22231610.
McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, 외. (October 2018). “Effect of Aspirin on Disability-free Survival in the Healthy Elderly”. 《The New England Journal of Medicine》 379 (16): 1499–1508. doi:10.1056/NEJMoa1800722. hdl:1885/154654. PMC 6426126. PMID 30221596.
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, 외. (October 2018). “Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly”. 《The New England Journal of Medicine》 379 (16): 1509–1518. doi:10.1056/NEJMoa1805819. PMC 6289056. PMID 30221597.
Algra AM, Rothwell PM (May 2012). “Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials”. 《The Lancet. Oncology》 13 (5): 518–27. doi:10.1016/S1470-2045(12)70112-2. PMID 22440112.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, 외. (April 2022). “Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement”. 《JAMA》 327 (16): 1577–1584. doi:10.1001/jama.2022.4983. PMID 35471505. S2CID 248390304.
Sachs CJ (March 2005). “Oral analgesics for acute nonspecific pain”. 《American Family Physician》 71 (5): 913–8. PMID 15768621.
Gaciong Z (June 2003). “The real dimension of analgesic activity of aspirin”. 《Thrombosis Research》 110 (5–6): 361–4. doi:10.1016/j.thromres.2003.08.009. PMID 14592563.
Derry CJ, Derry S, Moore RA (December 2014). “Caffeine as an analgesic adjuvant for acute pain in adults”. 《The Cochrane Database of Systematic Reviews》 2014 (12): CD009281. doi:10.1002/14651858.CD009281.pub3. PMC 6485702. PMID 25502052.
Hersh EV, Moore PA, Ross GL (May 2000). “Over-the-counter analgesics and antipyretics: a critical assessment”. 《Clinical Therapeutics》 22 (5): 500–48. doi:10.1016/S0149-2918(00)80043-0. PMID 10868553.
Mett A, Tfelt-Hansen P (June 2008). “Acute migraine therapy: recent evidence from randomized comparative trials”. 《Current Opinion in Neurology》 21 (3): 331–7. doi:10.1097/WCO.0b013e3282fee843. PMID 18451718. S2CID 44459366.
Kingery WS (November 1997). “A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes”. 《Pain》 73 (2): 123–139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498. S2CID 10418793.
Loder E, Rizzoli P (January 2008). “Tension-type headache”. 《BMJ》 336 (7635): 88–92. doi:10.1136/bmj.39412.705868.AD. PMC 2190284. PMID 18187725.
Gilmore B, Michael M (February 2011). “Treatment of acute migraine headache”. 《American Family Physician》 83 (3): 271–80. PMID 21302868.
Bartfai T, Conti B (March 2010). “Fever”. 《TheScientificWorldJournal》 10: 490–503. doi:10.1100/tsw.2010.50. PMC 2850202. PMID 20305990.
Pugliese A, Beltramo T, Torre D (October 2008). “Reye's and Reye's-like syndromes”. 《Cell Biochemistry and Function》 26 (7): 741–6. doi:10.1002/cbf.1465. PMID 18711704. S2CID 22361194.
Beutler AI, Chesnut GT, Mattingly JC, Jamieson B (December 2009). “FPIN's Clinical Inquiries. Aspirin use in children for fever or viral syndromes”. 《American Family Physician》 80 (12): 1472. PMID 20000310.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, 외. (September 2000). “Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin”. 《The American Journal of Gastroenterology》 95 (9): 2218–24. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Delaney JA, Opatrny L, Brophy JM, Suissa S (August 2007). “Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding”. 《CMAJ》 177 (4): 347–51. doi:10.1503/cmaj.070186. PMC 1942107. PMID 17698822.
Laine L, Maller ES, Yu C, Quan H, Simon T (August 2004). “Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial”. 《Gastroenterology》 127 (2): 395–402. doi:10.1053/j.gastro.2004.05.001. PMID 15300570.
Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, 외. (September 2003). “Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa”. 《Proceedings of the National Academy of Sciences of the United States of America》 100 (19): 10937–41. Bibcode:2003PNAS..10010937F. doi:10.1073/pnas.1933204100. PMC 196906. PMID 12960371.
Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, 외. (July 2007). “Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review”. 《Clinical Gastroenterology and Hepatology》 5 (7): 818–28, 828.e1–5; quiz 768. doi:10.1016/j.cgh.2007.03.011. PMID 17556027.
Doña I, Barrionuevo E, Salas M, Laguna JJ, Agúndez J, García-Martín E, 외. (November 2018). “NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs”. 《Scientific Reports》 8 (1): 16710. Bibcode:2018NatSR...816710D. doi:10.1038/s41598-018-34668-1. PMC 6232098. PMID 30420763.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, 외. (January 2019). “Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper”. 《Allergy》 74 (1): 28–39. doi:10.1111/all.13599. PMID 30216468. S2CID 52276808.
Sánchez-Borges M, Capriles-Hulett A (January 2000). “Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity”. 《Annals of Allergy, Asthma & Immunology》 84 (1): 101–6. doi:10.1016/S1081-1206(10)62748-2. PMID 10674573.
Stadelmann WK, Digenis AG, Tobin GR (August 1998). “Impediments to wound healing”. 《American Journal of Surgery》 176 (2A Suppl): 39S–47S. doi:10.1016/S0002-9610(98)00184-6. PMID 9777971.
Layton AM, Ibbotson SH, Davies JA, Goodfield MJ (July 1994). “Randomised trial of oral aspirin for chronic venous leg ulcers”. 《Lancet》 344 (8916): 164–5. doi:10.1016/s0140-6736(94)92759-6. PMID 7912767. S2CID 912169.
del Río Solá ML, Antonio J, Fajardo G, Vaquero Puerta C (July 2012). “Influence of aspirin therapy in the ulcer associated with chronic venous insufficiency”. 《Annals of Vascular Surgery》 26 (5): 620–9. doi:10.1016/j.avsg.2011.02.051. hdl:10324/2904. PMID 22437068.
de Oliveira Carvalho PE, Magolbo NG, De Aquino RF, Weller CD, 외. (Cochrane Wounds Group) (February 2016). “Oral aspirin for treating venous leg ulcers”. 《The Cochrane Database of Systematic Reviews》 2016 (2): CD009432. doi:10.1002/14651858.CD009432.pub2. PMC 8627253. PMID 26889740.
Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J (November 2017). “Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)”. 《BMJ》 359: j5157. doi:10.1136/bmj.j5157. PMC 5701114. PMID 29175902.
Tilbrook H, Clark L, Cook L, Bland M, Buckley H, Chetter I, 외. (October 2018). “AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial”. 《Health Technology Assessment》 22 (55): 1–138. doi:10.3310/hta22550. PMC 6204573. PMID 30325305.
Gaudreault P, Temple AR, Lovejoy FH (October 1982). “The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison”. 《Pediatrics》 70 (4): 566–9. doi:10.1542/peds.70.4.566. PMID 7122154. S2CID 12738659. (primary source)
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). “Serum concentrations of salicylic acid following topically applied salicylate derivatives”. 《The Annals of Pharmacotherapy》 30 (9): 935–40. doi:10.1177/106002809603000903. PMID 8876850. S2CID 9843820.
Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, 외. (September 2005). “Significance of salicylate intolerance in diseases of the lower gastrointestinal tract” (PDF). 《Journal of Physiology and Pharmacology》 56 (Suppl 5): 89–102. PMID 16247191. 2011년 4월 9일에 원본 문서 (PDF)에서 보존된 문서.
Senna GE, Andri G, Dama AR, Mezzelani P, Andri L (1995). “Tolerability of imidazole salycilate in aspirin-sensitive patients”. 《Allergy Proceedings》 16 (5): 251–4. doi:10.2500/108854195778702675. PMID 8566739.
Macdonald S (November 2002). “Aspirin use to be banned in under 16 year olds”. 《BMJ》 325 (7371): 988c–988. doi:10.1136/bmj.325.7371.988/c. PMC 1169585. PMID 12411346.
Alqahtani Z, Jamali F (2018). “Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review”. 《Journal of Pharmacy & Pharmaceutical Sciences》 21 (1s): 48s–73s. doi:10.18433/jpps29854. PMID 29891025. S2CID 48361086.
Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N (April 2008). “The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers”. 《The American Journal of Cardiology》 101 (7): 1060–1063. doi:10.1016/j.amjcard.2007.11.054. PMID 18359332.
Hollifield JW (August 1976). “Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.”. 《Southern Medical Journal》 69 (8): 1034–6. doi:10.1097/00007611-197608000-00022. PMID 785608.
Loh HS, Watters K, Wilson CW (1973년 11월 1일). “The effects of aspirin on the metabolic availability of ascorbic acid in human beings”. 《Journal of Clinical Pharmacology》 13 (11): 480–486. doi:10.1002/j.1552-4604.1973.tb00203.x. PMID 4490672.
Basu TK (1982). “Vitamin C-aspirin interactions”. 《International Journal for Vitamin and Nutrition Research. Supplement》 23: 83–90. PMID 6811490.
Ioannides C, Stone AN, Breacker PJ, Basu TK (December 1982). “Impairment of absorption of ascorbic acid following ingestion of aspirin in guinea pigs”. 《Biochemical Pharmacology》 31 (24): 4035–4038. doi:10.1016/0006-2952(82)90652-9. PMID 6818974.
Ferguson RK, Boutros AR (August 1970). “Death following self-poisoning with aspirin”. 《JAMA》 213 (7): 1186–8. doi:10.1001/jama.213.7.1186. PMID 5468267.
Kaufman FL, Dubansky AS (April 1972). “Darvon poisoning with delayed salicylism: a case report”. 《Pediatrics》 49 (4): 610–1. doi:10.1542/peds.49.4.610. PMID 5013423. S2CID 29427204.
Levy G, Tsuchiya T (August 1972). “Salicylate accumulation kinetics in man”. 《The New England Journal of Medicine》 287 (9): 430–2. doi:10.1056/NEJM197208312870903. PMID 5044917.
Grootveld M, Halliwell B (January 1988). “2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism”. 《Biochemical Pharmacology》 37 (2): 271–80. doi:10.1016/0006-2952(88)90729-0. PMID 3342084.
Hartwig-Otto H (November 1983). “Pharmacokinetic considerations of common analgesics and antipyretics”. 《The American Journal of Medicine》 75 (5A): 30–7. doi:10.1016/0002-9343(83)90230-9. PMID 6606362.
Done AK (November 1960). “Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion”. 《Pediatrics》 26: 800–7. doi:10.1542/peds.26.5.800. PMID 13723722. S2CID 245036862.
Chyka PA, Erdman AR, Christianson G, Wax PM, Booze LL, Manoguerra AS, 외. (2007). “Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management”. 《Clinical Toxicology》 45 (2): 95–131. doi:10.1080/15563650600907140. PMID 17364628.
Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT (November 1982). “Diuresis or urinary alkalinisation for salicylate poisoning?”. 《British Medical Journal》 285 (6352): 1383–6. doi:10.1136/bmj.285.6352.1383. PMC 1500395. PMID 6291695.
Dargan PI, Wallace CI, Jones AL (May 2002). “An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose”. 《Emergency Medicine Journal》 19 (3): 206–9. doi:10.1136/emj.19.3.206. PMC 1725844. PMID 11971828.
D'Agati V (July 1996). “Does aspirin cause acute or chronic renal failure in experimental animals and in humans?”. 《American Journal of Kidney Diseases》 28 (1 Suppl 1): S24–9. doi:10.1016/s0272-6386(96)90565-x. PMID 8669425.

personalmd.com

“Oral Aspirin information”. First DataBank. 2000년 9월 18일에 원본 문서에서 보존된 문서. 2008년 5월 8일에 확인함.

semanticscholar.org

api.semanticscholar.org

Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, 외. (April 2022). “Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement”. 《JAMA》 327 (16): 1577–1584. doi:10.1001/jama.2022.4983. PMID 35471505. S2CID 248390304.
Mett A, Tfelt-Hansen P (June 2008). “Acute migraine therapy: recent evidence from randomized comparative trials”. 《Current Opinion in Neurology》 21 (3): 331–7. doi:10.1097/WCO.0b013e3282fee843. PMID 18451718. S2CID 44459366.
Kingery WS (November 1997). “A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes”. 《Pain》 73 (2): 123–139. doi:10.1016/S0304-3959(97)00049-3. PMID 9415498. S2CID 10418793.
Pugliese A, Beltramo T, Torre D (October 2008). “Reye's and Reye's-like syndromes”. 《Cell Biochemistry and Function》 26 (7): 741–6. doi:10.1002/cbf.1465. PMID 18711704. S2CID 22361194.
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, 외. (September 2000). “Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin”. 《The American Journal of Gastroenterology》 95 (9): 2218–24. doi:10.1111/j.1572-0241.2000.02248.x. PMID 11007221. S2CID 33742424.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, 외. (January 2019). “Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper”. 《Allergy》 74 (1): 28–39. doi:10.1111/all.13599. PMID 30216468. S2CID 52276808.
Layton AM, Ibbotson SH, Davies JA, Goodfield MJ (July 1994). “Randomised trial of oral aspirin for chronic venous leg ulcers”. 《Lancet》 344 (8916): 164–5. doi:10.1016/s0140-6736(94)92759-6. PMID 7912767. S2CID 912169.
Gaudreault P, Temple AR, Lovejoy FH (October 1982). “The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison”. 《Pediatrics》 70 (4): 566–9. doi:10.1542/peds.70.4.566. PMID 7122154. S2CID 12738659. (primary source)
Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA (September 1996). “Serum concentrations of salicylic acid following topically applied salicylate derivatives”. 《The Annals of Pharmacotherapy》 30 (9): 935–40. doi:10.1177/106002809603000903. PMID 8876850. S2CID 9843820.
Alqahtani Z, Jamali F (2018). “Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review”. 《Journal of Pharmacy & Pharmaceutical Sciences》 21 (1s): 48s–73s. doi:10.18433/jpps29854. PMID 29891025. S2CID 48361086.
Kaufman FL, Dubansky AS (April 1972). “Darvon poisoning with delayed salicylism: a case report”. 《Pediatrics》 49 (4): 610–1. doi:10.1542/peds.49.4.610. PMID 5013423. S2CID 29427204.
Done AK (November 1960). “Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion”. 《Pediatrics》 26: 800–7. doi:10.1542/peds.26.5.800. PMID 13723722. S2CID 245036862.

snu.ac.kr

hqcenter.snu.ac.kr

중년이 되면 아스피린을 먹어야 하나요?, 서울대학교 의과대학 국민건강지식센터

uspreventiveservicestaskforce.org

본 문서에는 현재 퍼블릭 도메인에 속한 다음 저작물을 기초로 작성된 내용이 포함되어 있습니다: “Aspirin for the prevention of cardiovascular disease”. U.S. Preventive Services Task Force. 2012년 7월 11일에 원본 문서에서 보존된 문서. 2012년 7월 26일에 확인함.

web.archive.org

“Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more”. 《Medscape Reference》. WebMD. 2014년 4월 7일에 원본 문서에서 보존된 문서. 2014년 4월 3일에 확인함.
“Aspirin”. American Society of Health-System Pharmacists. 2021년 11월 29일. 2017년 4월 25일에 원본 문서에서 보존된 문서 – Drugs.com 경유.
Jeffreys D (2008). 《Aspirin the remarkable story of a wonder drug.》. Bloomsbury Publishing USA. ISBN 978-1-59691-816-0. 2017년 9월 8일에 원본 문서에서 보존된 문서. ^:46–48
본 문서에는 현재 퍼블릭 도메인에 속한 다음 저작물을 기초로 작성된 내용이 포함되어 있습니다: “Aspirin for reducing your risk of heart attack and stroke: know the facts”. U.S. Food and Drug Administration (FDA). 2012년 8월 14일에 원본 문서에서 보존된 문서. 2012년 7월 26일에 확인함.
본 문서에는 현재 퍼블릭 도메인에 속한 다음 저작물을 기초로 작성된 내용이 포함되어 있습니다: “Aspirin for the prevention of cardiovascular disease”. U.S. Preventive Services Task Force. 2012년 7월 11일에 원본 문서에서 보존된 문서. 2012년 7월 26일에 확인함.
“Medications Used to Treat Fever”. American Academy of Pediatrics. 2013년 2월 18일에 원본 문서에서 보존된 문서. 2012년 11월 25일에 확인함.
“51 FR 8180” (PDF). 《United States Federal Register》 51 (45). 1986년 3월 7일. 2011년 8월 19일에 원본 문서 (PDF)에서 보존된 문서.
“Are You Sensitive to Aspirin? Here are Some Reasons Why”. 《Health Essentials from Cleveland Clinic》. 2015년 2월 5일. 2020년 10월 25일에 원본 문서에서 보존된 문서. 2020년 3월 5일에 확인함.
Kreplick LW (2001). “Salicylate toxicity in emergency medicine”. Medscape. 2012년 8월 31일에 원본 문서에서 보존된 문서.
“Aspirin information from Drugs.com”. Drugs.com. 2008년 5월 9일에 원본 문서에서 보존된 문서. 2008년 5월 8일에 확인함.
“Oral Aspirin information”. First DataBank. 2000년 9월 18일에 원본 문서에서 보존된 문서. 2008년 5월 8일에 확인함.
Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, 외. (September 2005). “Significance of salicylate intolerance in diseases of the lower gastrointestinal tract” (PDF). 《Journal of Physiology and Pharmacology》 56 (Suppl 5): 89–102. PMID 16247191. 2011년 4월 9일에 원본 문서 (PDF)에서 보존된 문서.
“PDR guide to over the counter (OTC) drugs”. 2008년 4월 10일에 원본 문서에서 보존된 문서. 2008년 4월 28일에 확인함.
“Dengue and dengue hemorrhagic fever: information for health care practitioners”. 2008년 3월 17일에 원본 문서에서 보존된 문서. 2008년 4월 28일에 확인함.
“Acetylsalicylic acid”. 《NIOSH Pocket Guide to Chemical Hazards》. U.S. National Institute for Occupational Safety and Health (NIOSH). 2016년 4월 11일. 2017년 5월 11일에 원본 문서에서 보존된 문서.
Edwards SH. “Nonsteroidal Anti-inflammatory Drugs: Aspirin”. 《Merck Veterinary Manual》. 2016년 12월 18일에 원본 문서에서 보존된 문서. 2018년 1월 20일에 확인함.
“Analgesics (toxicity)”. Merck. 2015년 4월 11일에 원본 문서에서 보존된 문서. 2018년 1월 19일에 확인함.
“Plants poisonous to livestock”. Cornell University Department of Animal Science. 2015년 8월 16일에 원본 문서에서 보존된 문서. 2016년 3월 3일에 확인함.